News
Basel, Switzerland, Thursday, 03.04.2025 – Today NBETherapeutics (NBE)a wholly owned subsidiary of Boehringer Ingelheim,officially openedits new ADC R&D facilityin Basel. This milestone ...
Today NBE Therapeutics (NBE) a wholly owned subsidiary of Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel. This milestone reinforces its commitment to innovation in oncology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback